Biotech Recursion Pharma Drops Back To IPO Price β Again.
Lady scientist in microbiology laboratory getty Itβs got all the correct buzzwords for a hot biotech stock: machine learning, cell images, artificial intelligence. When Recursion Pharmaceutical went public at $18/share back in April, the stock immediately popped up to almost $36/share, a nice double for those lucky enough to merit an IPO allocation. After selling …
Biotech Recursion Pharma Drops Back To IPO Price β Again. Read More »